question
stringlengths 18
168
| answer
stringlengths 1
209
⌀ |
|---|---|
Which enzyme is inhibited by Orteronel? | CYP17A1 |
Which enzyme is inhibited by Orteronel? | CYP17A1 |
Which enzyme is inhibited by Orteronel? | CYP17A1 |
Which enzyme is inhibited by Orteronel? | CYP17A1 |
Which enzyme is inhibited by Orteronel? | CYP17A1 |
Which enzyme is inhibited by Orteronel? | CYP17A1 |
Which enzyme is inhibited by Orteronel? | CYP17A1 |
Which enzyme is inhibited by Orteronel? | CYP17A1 |
Which enzyme is inhibited by Orteronel? | CYP17A1 |
Which enzyme is inhibited by Orteronel? | CYP17A1 |
Which enzyme is inhibited by Orteronel? | CYP17A1 |
Which enzyme is inhibited by Orteronel? | CYP17A1 |
Which enzyme is inhibited by Orteronel? | CYP17A1 |
Which enzyme is inhibited by Orteronel? | CYP17A1 |
Which enzyme is inhibited by Orteronel? | CYP17A1 |
Which enzyme is inhibited by Orteronel? | CYP17A1 |
Which enzyme is targeted by Evolocumab? | proprotein convertase subtilisin/kexin type 9 |
Which enzyme is targeted by Evolocumab? | proprotein convertase subtilisin/kexin type 9 |
Which enzyme is targeted by Evolocumab? | proprotein convertase subtilisin/kexin type 9 |
Which enzyme is targeted by Evolocumab? | proprotein convertase subtilisin/kexin type 9 |
Which enzyme is targeted by Evolocumab? | proprotein convertase subtilisin/kexin type 9 |
Which enzyme is targeted by Evolocumab? | proprotein convertase subtilisin/kexin type 9 |
Which enzyme is targeted by Evolocumab? | proprotein convertase subtilisin/kexin type 9 |
Which enzyme is targeted by Evolocumab? | proprotein convertase subtilisin/kexin type 9 |
Which enzyme is targeted by Evolocumab? | proprotein convertase subtilisin/kexin type 9 |
Which enzyme is targeted by Evolocumab? | proprotein convertase subtilisin/kexin type 9 |
Which enzyme is targeted by Evolocumab? | proprotein convertase subtilisin/kexin type 9 |
Which enzyme is targeted by Evolocumab? | proprotein convertase subtilisin/kexin type 9 |
Which enzyme is targeted by Evolocumab? | proprotein convertase subtilisin/kexin type 9 |
Which molecule is targeted by a monoclonal antibody Secukinumab? | interleukin-17A |
Which molecule is targeted by a monoclonal antibody Secukinumab? | interleukin-17A |
Which molecule is targeted by a monoclonal antibody Secukinumab? | interleukin-17A |
Which molecule is targeted by a monoclonal antibody Secukinumab? | interleukin-17A |
Which molecule is targeted by a monoclonal antibody Secukinumab? | interleukin-17A |
Which molecule is targeted by a monoclonal antibody Secukinumab? | interleukin-17A |
Which molecule is targeted by a monoclonal antibody Secukinumab? | interleukin-17A |
Which molecule is targeted by a monoclonal antibody Secukinumab? | interleukin-17A |
Which molecule is targeted by a monoclonal antibody Secukinumab? | interleukin-17A |
What family do mDia proteins belong in? | mDia proteins are members of the formin family |
What is generic name of drug Adempas? | Riociguat |
What is generic name of drug Adempas? | Riociguat |
What is generic name of drug Adempas? | riociguat |
What is generic name of drug Adempas? | riociguat |
What is generic name of drug Adempas? | Riociguat |
What is generic name of drug Adempas? | Riociguat |
What is generic name of drug Adempas? | Riociguat |
What is generic name of drug Adempas? | Riociguat |
What is generic name of drug Adempas? | Riociguat |
What is generic name of drug Adempas? | Riociguat |
What is generic name of drug Adempas? | riociguat |
What is generic name of drug Adempas? | Riociguat |
Where in the cell does the proteins S100A4 and p53 interact ? | nucleus |
Where in the cell does the proteins S100A4 and p53 interact ? | nucleus |
What is the disease in which patients are sensitive to DNA crosslinking agents, presenting with a high frequency of chromosomal aberrations? | Fanconi anemia |
What is the disease in which patients are sensitive to DNA crosslinking agents, presenting with a high frequency of chromosomal aberrations? | Fanconi anemia |
What is the disease in which patients are sensitive to DNA crosslinking agents, presenting with a high frequency of chromosomal aberrations? | Fanconi anemia |
What is the disease in which patients are sensitive to DNA crosslinking agents, presenting with a high frequency of chromosomal aberrations? | Fanconi anemia |
What is the disease in which patients are sensitive to DNA crosslinking agents, presenting with a high frequency of chromosomal aberrations? | Fanconi anemia |
What is the presumed key event in Fanconi anemia pathogenesis? | FancD2 monoubiquitination |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
Which SWI/SNF protein complex subunit has been demonstrated to interact with the FANCA gene product? | BRG1 |
DX-88 is investigational name of which drug? | Ecallantide |
DX-88 is investigational name of which drug? | Ecallantide |
DX-88 is investigational name of which drug? | ecallantide |
DX-88 is investigational name of which drug? | Ecallantide |
DX-88 is investigational name of which drug? | Ecallantide |
DX-88 is investigational name of which drug? | ecallantide |
DX-88 is investigational name of which drug? | ecallantide |
DX-88 is investigational name of which drug? | ecallantide |
DX-88 is investigational name of which drug? | Ecallantide |
DX-88 is investigational name of which drug? | Ecallantide |
DX-88 is investigational name of which drug? | ecallantide |
How many disulfide bridges has the protein hepcidin got? | Hepcidin contains eight cysteine residues that form four disulfide bridges |
LY450139 is investigational name of which drug? | Semagacestat |
LY450139 is investigational name of which drug? | semagacestat |
LY450139 is investigational name of which drug? | semagacestat |
LY450139 is investigational name of which drug? | Semagacestat |
LY450139 is investigational name of which drug? | semagacestat |
LY450139 is investigational name of which drug? | semagacestat |
LY450139 is investigational name of which drug? | semagacestat |